BSE filing, NSE: URBANCO. Summary written from the filing by ALFA Finder's alert engine.
Urban Company Ltd: key numbers
- Share price
- ₹145.10
- Market cap
- ₹22,377 Cr
- Revenue (annual)
- ₹1,556 Cr
- Net profit (annual)
- ₹-234.8 Cr
- P/E (TTM)
- -49.0×Sector 34.0×
- Promoter holding
- 19.02%+0.00% QoQ
- FII holding
- 52.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Urban Company Ltd
All →Urban Company Earnings Call Transcript: Key Takeaways
Urban Company reported a sharp 41.4% revenue jump, yet management's pivot to a ₹2,500 Cr capital raise despite a strong cash balance suggests aggressive M&A or high-stakes competitive defense in InstaHelp.
Urban Company Annual General Meeting
Urban Company has issued a postal ballot notice to seek shareholder approval for raising up to ₹2,500 crore through an issuance of securities.
Urban Company Fund Raise of ₹2,500 Cr
Urban Company's board approved a fresh capital raise of up to ₹2,500 Cr. Additionally, Q2 FY27 revenue grew 41% YoY to ₹537 Cr.
- Value
- ₹2,500 Cr
Urban Company Business Update
Urban Company released its Q2 FY27 Shareholders' Letter, reporting strong growth momentum across core segments and announcing board approval to raise capital up to ₹2,500 Crore.
- Value
- ₹2,500 Cr
Urban Company Q2 FY27 Results: Net Loss of ₹182.5 Cr, Loss Widens
Urban Company Ltd reported revenue from operations of ₹537.3 Cr (+41.4% YoY) and a net loss of ₹182.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹182.5 Cr
Urban Company Other Announcement
Urban Company Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.